Juric D, Song K, Johnson RM, Accordino MK, et al. PI3Kalpha Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models. Clin Cancer Res 2026;32:56-75.
PMID: 41143603